TT-4 as a Single Agent in Subjects With Advanced Selected Solid Tumors
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2384438
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety and tolerability of orally administered TT-4 in subjects with advanced selected solid tumors. The dose escalation portion of the study will determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) of TT-4.
创建时间：
2022-12-15
